These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28420650)

  • 81. Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics.
    Li N; Wang X; Xu Y; Lin Y; Zhu N; Liu P; Lu D; Si S
    Mol Pharmacol; 2017 Apr; 91(4):264-276. PubMed ID: 28087808
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling.
    Yoshikawa T; Ide T; Shimano H; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Yatoh S; Kitamine T; Okazaki H; Tamura Y; Sekiya M; Takahashi A; Hasty AH; Sato R; Sone H; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1240-54. PubMed ID: 12730331
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Pharmacological activation of liver X receptor during cigarette smoke exposure adversely affects alveolar macrophages and pulmonary surfactant homeostasis.
    Jubinville É; Routhier J; Maranda-Robitaille M; Pineault M; Milad N; Talbot M; Beaulieu MJ; Aubin S; Paré MÈ; Laplante M; Morissette MC
    Am J Physiol Lung Cell Mol Physiol; 2019 Apr; 316(4):L669-L678. PubMed ID: 30702343
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Liver X receptor α promotes the synthesis of monounsaturated fatty acids in goat mammary epithelial cells via the control of stearoyl-coenzyme A desaturase 1 in an SREBP-1-dependent manner.
    Yao DW; Luo J; He QY; Xu HF; Li J; Shi HB; Wang H; Chen Z; Loor JJ
    J Dairy Sci; 2016 Aug; 99(8):6391-6402. PubMed ID: 27209141
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
    Wu G; Wang Q; Xu Y; Li J; Zhang H; Qi G; Xia Q
    Cell Death Dis; 2019 May; 10(6):416. PubMed ID: 31138790
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Group X secretory phospholipase A2 negatively regulates ABCA1 and ABCG1 expression and cholesterol efflux in macrophages.
    Shridas P; Bailey WM; Gizard F; Oslund RC; Gelb MH; Bruemmer D; Webb NR
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):2014-21. PubMed ID: 20844270
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Activation of liver X receptor regulates fatty acid synthase expression in diabetic liver].
    Wang B; Cheng LJ; Gao ZN; Zhang XY; Huo M; Zhang DJ; Wu J; Wei MF
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):848-52. PubMed ID: 18756992
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Regulation of bile acid, cholesterol, and fatty acid synthesis in chicken primary hepatocytes by different concentrations of T0901317, an agonist of liver X receptors.
    Sato K; Kamada T
    Comp Biochem Physiol A Mol Integr Physiol; 2011 Feb; 158(2):201-6. PubMed ID: 21056113
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Regulation of hepatic fatty acid elongase 5 by LXRalpha-SREBP-1c.
    Qin Y; Dalen KT; Gustafsson JA; Nebb HI
    Biochim Biophys Acta; 2009 Feb; 1791(2):140-7. PubMed ID: 19136075
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effect of synthetic ligands of PPAR α, β/δ, γ, RAR, RXR and LXR on the fatty acid composition of phospholipids in mice.
    Weiss K; Mihály J; Liebisch G; Marosvölgyi T; Schmitz G; Decsi T; Rühl R
    Lipids; 2011 Nov; 46(11):1013-20. PubMed ID: 21792736
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Hemistepsin A inhibits T0901317-induced lipogenesis in the liver.
    Kim JK; Cho IJ; Kim EO; Lee DG; Jung DH; Ki SH; Ku SK; Kim SC
    BMB Rep; 2021 Feb; 54(2):106-111. PubMed ID: 32843130
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression.
    Seo JB; Moon HM; Kim WS; Lee YS; Jeong HW; Yoo EJ; Ham J; Kang H; Park MG; Steffensen KR; Stulnig TM; Gustafsson JA; Park SD; Kim JB
    Mol Cell Biol; 2004 Apr; 24(8):3430-44. PubMed ID: 15060163
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Hepatic TRAP80 selectively regulates lipogenic activity of liver X receptor.
    Kim GH; Oh GS; Yoon J; Lee GG; Lee KU; Kim SW
    J Clin Invest; 2015 Jan; 125(1):183-93. PubMed ID: 25437875
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Fowl Adenovirus Serotype 4 Induces Hepatic Steatosis via Activation of Liver X Receptor-α.
    Yuan F; Hou L; Wei L; Quan R; Wang J; Liu H; Liu J
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361420
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A role for protein inhibitor of activated STAT1 (PIAS1) in lipogenic regulation through SUMOylation-independent suppression of liver X receptors.
    Zhang Y; Gan Z; Huang P; Zhou L; Mao T; Shao M; Jiang X; Chen Y; Ying H; Cao M; Li J; Li J; Zhang WJ; Yang L; Liu Y
    J Biol Chem; 2012 Nov; 287(45):37973-85. PubMed ID: 22969086
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8.
    Yu L; York J; von Bergmann K; Lutjohann D; Cohen JC; Hobbs HH
    J Biol Chem; 2003 May; 278(18):15565-70. PubMed ID: 12601003
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Sulfation of 25-hydroxycholesterol by SULT2B1b decreases cellular lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells.
    Bai Q; Xu L; Kakiyama G; Runge-Morris MA; Hylemon PB; Yin L; Pandak WM; Ren S
    Atherosclerosis; 2011 Feb; 214(2):350-6. PubMed ID: 21146170
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
    Kratzer A; Buchebner M; Pfeifer T; Becker TM; Uray G; Miyazaki M; Miyazaki-Anzai S; Ebner B; Chandak PG; Kadam RS; Calayir E; Rathke N; Ahammer H; Radovic B; Trauner M; Hoefler G; Kompella UB; Fauler G; Levi M; Levak-Frank S; Kostner GM; Kratky D
    J Lipid Res; 2009 Feb; 50(2):312-26. PubMed ID: 18812595
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor.
    Quinet EM; Savio DA; Halpern AR; Chen L; Miller CP; Nambi P
    J Lipid Res; 2004 Oct; 45(10):1929-42. PubMed ID: 15292374
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRalpha.
    Lehrke M; Lebherz C; Millington SC; Guan HP; Millar J; Rader DJ; Wilson JM; Lazar MA
    Cell Metab; 2005 May; 1(5):297-308. PubMed ID: 16054077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.